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E-mail address: ghriazi@ibb.ut.ac.ir (G. Riazi).Structural integrity of microtubule protein (MTP) is pivotal for its physiological roles. Disruption of
the MTP network is known to be involved in neurodegenerative disorders. The gum resin of plants
of the boswellia species, with b-boswellic acid (BBA) as the major component, has long been used in
Ayurveda and Oriental Medicine to prevent amnesia. In the current study, we addressed the ques-
tion whether BBA affects assembly dynamics behavior of tubulin. Our in vitro results revealed that
BBA increases MTP length distribution and the polymerization rate of tubulin, moderately stabiliz-
ing it and diminishing both the critical concentration (Cc) and the fraction of inactive tubulin (Fi).
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Polymerization dynamics and stability are the key factors in
microtubule protein (MTP) physiological functions such as mitosis,
meiosis, cell motility and axonal vesicles transport [1]. Disruption
of MTP organization impairs the axonal transport and lead to mem-
ory loss, induced by synaptic death [2,3]. There are several reports
indicating that disruption of MTP integrity is the leading cause for
neurodegenerative disorders such as Alzheimer‘s disease (AD) [4–
7]. Tau protein isoforms maintain the stability of MTP in central
nervous system. These isoforms undergo some changes, like hyper-
phosphorylation, and dissociates from MTP, in pathophysiological
conditions [8]. Consequently, MTP assembly dynamics perturb
and detached tau isoforms oligemerize to form neuroﬁbrillary tan-
gles (NFTs), the hallmarks of AD [9]. Therefore, it is to be likely that
principal factor which induces memory impairment and loss in AD
state, is related to MTP dynamics and destabilization [3,7,10].
The gum resin of plants boswellia species, from Burceraceae
family, has long been used for the prevention of amnesia andchemical Societies. Published by E
anic Laboratory, Institute of
17614411, Tehran, Iran. Fax:enhancement of memory power in Ayurveda and Oriental Medi-
cine. Ayurveda provides an integrated approach for preventing
and treating illness through lifestyle interventions and natural
therapies [11,12]. Chewing the boswellia gum for elderly, was
highly recommended by Persian physician, Avicenna in the canon
of medicine [13]. Also, it has been demonstrated that the gum resin
of boswellia improves remedy of rheumatoid arthritis and inﬂam-
mation [14–16]. The gum resin consists of different terpenoids and
b-boswellic acid (BBA) has been reported to be the major compo-
nent [16].
Considering the critical role of MTP stability and assembly
dynamics in neurodegenerative disorders besides the importance
of boswellia resin in prevention and remedy of memory associated
diseases, we planned to identify the role of BBA, in stability and
assembly behaviors of MTP in an in vitro study.
2. Materials and methods
2.1. Materials
Ethylenebis (oxyethylenenitrilo) tetraacetic acid (EGTA), guano-
sine 50 triphosphate type II-S (GTP), adenosine 50 triphosphate
(ATP), phenylmethylsulphonyl ﬂuoride (PMSF), glycerol, dimethyl
sulfoxide (DMSO) and MgSO4 were purchased from Sigmalsevier B.V. All rights reserved.
Table 1
Parameters of MTP assembly induced by BBA. The initial rate of turbidity increase
(OD/min) and the maximum turbidity after assembly (ODmax at 350 nm) were derived
from turbidimetric assay of tubulin (2.5 mg/ml) assembly, in the absence or presence
of BBA. Values represent the mean ± S.D. from three independent experiments.
BBA (lM) Tubulin (no
BBA)
Tubulin + BBA
0 150 300
Initial rate (OD/Min) 0.0198 ± 0.004 0.0282 ± 0.006 0.0361 ± 0.007
Maximum OD (350
nm)
0.1873 ± 0.081 0.2857 ± 0.069 0.3632 ± 0.047
Fig. 1. MTP assembly/disassembly assays in the presence or absence of BBA MTP assembly at 37 C (A) and disassembly at 10 C (B), as determined by turbidimetry at
350 nm, was performed by incubating of tubulin (25 lM) without (h) or with 150 lM (j) and 300 lM (N) of BBA in assembly buffer.
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(PIPES) was purchased from Merck (Darmstadt, Germany). Phos-
phocellulose type P-11 was prepared from Whatman Company.
BBA was a generous gift from Prof. Thomas Simmet (Department
of Pharmacology of Natural Products and Clinical Pharmacology,
University of Ulm, D-89081 Ulm, Germany). It was dissolved in
DMSO 20 mM as a vehicle (not more than 4% v/v). MgSO4 (1 M)
was added to both GTP and ATP stock solutions (100 mM) as a ratio
of 1:10 (v/v). Nanopure water was used in all experiments.
2.2. Tubulin preparation
MTP was prepared from cow brain after homogenization in the
PIPES buffer (100 mM PIPES pH 6.9, 1 mM EGTA, 1 mM MgSO4,
1 mM PMSF and 1 mM MgATP), followed by two cycles of temper-
ature dependent assembly and disassembly induced by 1 mM
MgGTP [17]. PEMG (100 mM PIPES pH 6.9, 2 mM MgSO4, 1 mM
EGTA, and 3.4 M glycerol) was used as assembly buffer. To obtain
puriﬁed and MAP-free tubulin (PC-tubulin), the crude tubulin sam-
ple was applied to a phosphocellulose column [18], eluted fractions
were promptly frozen in the liquid nitrogen, and stored at 70 C
for further experiments within 2 weeks. The resulting tubulin
was essentially pure (>97%) as determined by Coomassie Blue
staining of 10% SDS–PAGE [19].2.3. MTP assembly/disassembly assays
To examine the contribution of BBA in tubulin assembly/disas-
sembly dynamics, stored MTP aliquots were thawed and clariﬁed
by centrifugation (30,000 g, 15 min, at 4 C) to remove aggregates
and adjusted to ﬁnal concentration of 2.5 mg/ml in PEMG buffer.
MTP assembly was induced by adding 1 mM MgGTP at 37 C in
the presence or absence of BBA (150 and 300 lM). Assembly pro-
cess was followed by recording of absorbance of 350 nm, using a
Cary-100 (Varian, AU) UV/Vis spectrophotometer. Disassembly
was induced by adjusting the temperature of reaction to 10 C.
Fig. 2. Determination of the critical concentration (Cc) and unassembled fractions
of tubulin (Fi), in the absence (h) or presence of 150 lM (j) and 300 lM (N) of BBA.
Preassembled MTP samples were pre-achieved to steady state at different total
tubulin concentrations (Ct) and separated from unassembled tubulin in the
supernatant (Cs). Cs is plotted against Ct, giving an apparent Cc as the intercept
and Fi as the slope. Each point is the average of three measurements and the lines
are the results after a linear curve ﬁtting process for each group.
Table 2
Measurement of the critical concentration (Cc) and unassembled fractions of tubulin
(Fi) in the presence or absence of BBA. All values are representations of the
mean ± S.D. from three independent determinations (see Section 2 for details).
BBA (lM) Tubulin (no BBA) Tubulin + BBA
0 150 300
Cc (mg/ml) 0.30 ± 0.024 0.27 ± 0.028 0.25 ± 0.027
Fi (mg/ml) 0.21 ± 0.042 0.16 ± 0.029 0.14 ± 0.033
Fig. 3. Electron micrograph represents of BBA-induced MTP assembly. MTP
polymerized in assembly conditions as described in Section 2, in the absence (A),
or presence of 300 lM BBA (B) and negative stained at steady state. To detect the
MTP with both ends clearly visible, the magniﬁcation was adjusted to 60,000 and
45,000 for control and BBA-incubated sample, respectively.
Table 3
Changes in MTP polymer length distribution in the presence or absence of various
concentrations of BBA. Data are presented as the mean value ±S.D. of MTP length.
BBA (lM) Tubulin (no BBA) Tubulin + BBA
0 150 300
MTP length (nm) 337.8 ± 13.4 429 ± 22.6 548.3 ± 18.8
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The critical concentration (Cc) and inactive protein fraction (Fi)
of MTP assembly were determined in the presence of BBA. To
achieve this, PC-tubulin (2.5 mg/ml) were assembled in the pres-
ence or absence of BBA (150 and 300 lM). At the steady state of
assembly, aliquots of the samples were diluted to different ﬁnal
concentrations (Ct). After re-establishment of the steady state,
MTP were separated from unassembled tubulin by ultracentrifuga-
tion (30,000 g, 15 min, at 4 C). Tubulin concentrations in the
supernatant (Cs) were measured and Cc and Fi considered as the
intercept and slope of Cs against Ct [20].
2.5. Electron microscopy and image analysis
MTP (2.5 mg/ml) was incubated in the absence or presence of
150 and 300 lM BBA and assembled for 50 min. Aliquots from
assembly buffer were placed on 200 mesh grids, coated with Form-
var-carbon, and stained dropwise with 2.0% uranyl acetate. The air
dried samples were examined in a Zeiss DSM-960 transmission
electron microscope, operated at 90 kV. Only MTP micrographs
with both ends clearly visible were captured. Average Length dis-
tribution of MTP lattices was assessed from representative electron
micrographs and analyzed using Sigma Scan software 3.0 (Jandel
Scientiﬁc; SigmaScan Pro).
2.6. Measurement of BBA binding to MTP
Titration curves for BBA binding to MTP were constructed as
follows. Samples were prepared by incubating BBA in increments(0–13.2 lM) to PC-tubulin (0.2 lM) in PEMG buffer and relative
intrinsic ﬂuorescence of tubulin was monitored in a Cary (Varian,
AU) Luminescence Spectrometer. Emission spectra were measured
from 300 to 500 nm using an excitation wavelength of 290 nm. The
emission intensity of BBA at excitation wavelength was not mark-
edly signiﬁcant. To obtain binding parameters, the ﬂorescence data
were analyzed using the equation:
log½ðF0  FÞ=F ¼ logKapp þ napplog½Q 
where F0 and F are the ﬂuorescence intensity in the absence or pres-
ences of BBA respectively. napp (apparent binding number) and
logKapp (Kapp = apparent binding constant) were considered as the
slope and intercept of a plot of log [(F0F)/F] against log[Q] [21,22].
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Each experiment was done in triplicate and data are the aver-
ages and standard deviations of three independent assessments.
Results were analyzed for statistical signiﬁcance using a two-tailed
student’s t test. Changes were considered signiﬁcant at P < 0.05. All
statistics were performed with Sigma Plot Version 12 (Systat Soft-
ware Inc., CA) and presented as the mean ± S.D.
2.8. Theoretical studies
In order to determine the binding site of BBA on tubulin, we
performed molecular dynamics (MD) simulation and docking stud-
ies. Simulation was done using the GROMACS package with G43a1
force ﬁeld [23,24]. The equilibrium geometries of the tubulin with
heteroatoms GTP and GDP (PDB: 1tub) were achieved using MD
simulation at 300 K. The entire system was minimized using the
steepest descent of 1000 steps followed by the conjugate gradients
of 9000 steps. To demonstrate the quality of the simulation data,
the root mean square deviation (RMSD) of protein backbone was
determined. The ﬁnal structure was employed as the main conﬁg-
uration for BBA binding studies. Autodock 3.0 package was used for
molecular blind docking [25], and pre-set calculation parameters
in Autodock 3.0 were considered as default.
3. Results and discussion
3.1. Assembly and disassembly assays
Physiological roles of MTP, such as maintenance of axonal
transportation, is widely depends on its dynamics instability and
assembly parameters [1]. Many studies have been performed
on the ability of various compounds to regulate MTP assemblyFig. 4. Fluorescence titration curves of tubulin with BBA. Fluorescence intensity was mea
at the ratio of 0–13.2 lM increments. Inset: plot of log [(F0F)/F] vs. log [Q].behaviors. To characterize the contribution of BBA into tubulin
assembly dynamics, we followed the increase of absorbance of
350 nm in vitro (Fig. 1A). The initial rate of assembly and the max-
imum turbidity at steady state were calculated from the curves and
presented in Table 1. The slope of linear parts of the curves is cor-
related with the initial rate of assembly. We observed an enhance-
ment of this rate in the presence of BBA, indicating an increase in
assembly rate induced by BBA (see Table 1). It has been reported
that maximum absorbance at 350 nm is related to MTP length dis-
tribution which is a reﬂection of the polymer mass [26]. Obviously,
there are signiﬁcant increases in the maximum absorbance at stea-
dy state, which can be attributed to the population of MTP poly-
mers in the BBA-induced assembly samples, in compare with
control. As shown in Fig. 1A, in the presence of BBA (300 lM),
the maximum turbidity at steady state is approximately twofolds
higher than control, suggesting a substantial increase in the aver-
age of polymer mass, or MTP length, induced by BBA.
In order to conﬁrm the attribution of maximum turbidity to the
MTP polymer mass, assembly was reversed by cooling the samples,
following reassembly, which indicated that the increase in OD350
could be mainly attributed to MTP length increase. As shown in
Fig. 1B, in the presence of BBA, disassembly rate was lower in com-
parison with the control experiment, implying an attenuation of
disassembly process induced by BBA and stabilization of MTP
structure.
3.2. Determination of Cc and Fi
To learn how BBA affects MTP assembly, critical concentration
of tubulin assembly was assessed, in the presence of BBA. To this
aim, various concentrations of preassembled tubulin (Ct) were
plotted against unassembled tubulin (Cs) in the supernatant, in
the presence or absence of BBA (Fig. 2). Intercept (Cc) and slopesured with 0.2 lM tubulin in PEMG buffer, pH 6.8 at 25 C. BBA concentrations were
4136 O. Karima et al. / FEBS Letters 586 (2012) 4132–4138(Fi) of this graph are summarized in Table 2. We found a decrease
of Cc and Fi, in a concentration-dependent manner of BBA, indicat-
ing an enhancement of the afﬁnity and incorporation of tubulin di-
mers to MTP.
3.3. Morphological studies
The change of OD 350 (Fig. 1A), is characteristic of the formation
of MTP [27], however, it is not clear what exact structure are beingFig. 5. Molecular dynamic simulation and docking studies of BBA-tubulin interaction. GD
(B) and GDP binding pocket (C) in b-tubulin.formed upon interaction with BBA. To achieve this, we performed
the negative electron microscopy and image analysis at steady
state, followed by incubating of MTP with BBA. Electron micro-
graphs (Fig. 3) and quantitative data analysis of MTP distribution
(Table 3) revealed that the length of MTP was markedly increased
in the presence of BBA, in compare with the control (21.4% for BBA
150 lM and 38.5% for BBA 300 lM). These ﬁndings are in consis-
tence with data obtained from assembly assays at 350 nm, indicat-
ing an increase in OD and stability of growing MTPs.P (blue) and BBA (yellow) binding pocket in b-tubulin (A). Residues surrounded BBA
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The effects of microenvironment on intrinsic ﬂuorescence
parameters have been extensively used in detection the binding
of ligands to proteins [28]. Therefore, the association of BBA with
tubulin was investigated by ﬂuorescence titration and binding
curve was constructed (Fig. 4). Data were analyzed and binding
parameters calculated as described in Materials and Methods.
The obtained results indicated one apparent binding site (napp =
0.8) with an apparent association constant (Kapp) of 0.1 
106 M1, implying a high afﬁnity site for BBA on tubulin heterodi-
mer. Moreover, achievement of a saturating maximum in titration
process, suggests a speciﬁc interaction of BBA with tubulin.
3.5. Simulation of BBA-tubulin interaction
Effective surface hydrophobicity inﬂuences the intermolecular
interactions, such as binding of small hydrophobic ligands with
macromolecules, suggesting a hydrophobic interaction between
BBA and b-tubulin. Theoretical and computational modeling stud-
ies have potential to make prediction of binding a ligand to a pro-
tein [29]. Understanding the association site and energy of binding,
that underlies BBA action to tubulin, is critical in the rational de-
sign of new drugs. If a region of the molecule is highly strained
(for example: in X-ray crystallography), the MD simulation at-
tempts to release the strain, leading to a native conformation,
which is possible to evaluate by changes in it RMSD. The tubulin
RMSD increased within 4 ns and then ﬂuctuated in nano-scale
around 0.3 nm till 10 ns, indicating that after elimination of the
unfavorable strains from X-ray geometry, tubulin acquired a rather
stable form, following an energy minimization (steepest descent of
1000 steps followed by the conjugate gradients of 9000 steps) for
maintaining the better structure [30]. Relevant structure of the
binding has been shown in Fig. 5. We found an energy score of
9.61 kcal/mol upon simulation of BBA interaction with GDP-
tubulin. Fig. 5A represents the pocket of BBA binding, which is lo-
cated beside the E-site in b-tubulin. This pocket interferes with
GDP pocket site in side chains of Cys11, Gln14, Leu206, Leu224
and Tyr221 (Fig. 5B and C), which may inﬂuence in GTPase activity
of b-tubulin.
One of the most remarkable properties of MTP is its ability to
display dynamic instability, by which it undergoes transitions be-
tween periods of slow growth and faster shortening [31,32]. It is
well accepted that this behavior is related to GTPase activity of
b-tubulin, which is required to assemble MTP. Earlier reports sug-
gested that the hydrolysis of GTP follows the addition of Tubulin-
GTP with a considerable delay, resulting formation of a stable
GTP-cap at the end of MTP [33]. Decreasing of the GTPase activity
of tubulin will stabilize GTP-cap [34–36]. Our data supported that
BBA intensiﬁes the rescue rate and at the same time decreases the
catastrophe, the frequency of switching between growing and
shortening, suggesting a decrease in GTPase activity and an in-
crease in GTP-cap size and stability in a way that MTP remained
stable and grew longer.
Stability of MTP, which is equal to axonal outgrowth and effec-
tive branching, may prevent axonal degeneration [37]. This stabil-
ity is highly depends on GTPase activity. For example, comparison
of MTP assembly in brains from young and old rats revealed a high-
er tubulin GTPase activity for old ones [38], indicating a perturbed
MTP integration in neurodegenerative brains. Moreover, it has
been supposed that microtubule stabilizer drugs may be useful
for prevention and treatment of neurodegenerative disorders by
maintenance of axonal transportation [4,6,39]. According to our
previous study, BBA enhanced hippocampal axonal outgrowth
and branching [40]. So, we can conclude that BBA could enhance
MTP structural integration by modulating GTPase activity andassembly dynamics. While, as reported here, our results are based
on in vitro conditions and the direct contribution of BBA on MTP
function has yet to be examined in vivo.
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